Report cover image

Global Anti-aging and Longevity Drugs Industry Growth and Trends Forecast to 2031

Publisher APO Research, Inc.
Published Jul 07, 2075
Length 111 Pages
SKU # APRC20263104

Description

Summary

According to APO Research, The global Anti-aging and Longevity Drugs market was estimated at US$ million in 2025 and is projected to reach a revised size of US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2026-2031.

North American market for Anti-aging and Longevity Drugs is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Asia-Pacific market for Anti-aging and Longevity Drugs is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Europe market for Anti-aging and Longevity Drugs is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

The major global manufacturers of Anti-aging and Longevity Drugs include Centrum, GNC, Herbalmax, HUM Nutrition, MegaFood, Natrol, Nature Made, Nature's Bounty and New Chapter, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Anti-aging and Longevity Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-aging and Longevity Drugs.

The Anti-aging and Longevity Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Anti-aging and Longevity Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Anti-aging and Longevity Drugs Segment by Company

Centrum
GNC
Herbalmax
HUM Nutrition
MegaFood
Natrol
Nature Made
Nature's Bounty
New Chapter
Pure Encapsulations
The Vitamin Shoppe
China Resources Double-Crane Pharmaceutical Co.,Ltd.
GeneHarbor (Hong Kong) Biotechnologies Limited
Xiamen Kingdomway Group Company
Shinkowa
Yaben Chemical
Guangdong Zhongsheng Pharmaceutical Co.,Ltd.
Anti-aging and Longevity Drugs Segment by Type

Resveratrol
Coenzyme Q10 and Collagen
Biotin
Vitamins
Nicotinamide Mononucleotide (NMN)
Others
Anti-aging and Longevity Drugs Segment by Application

Retail Pharmacies
Online Pharmacies
Hospitals
Clinics
Anti-aging and Longevity Drugs Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anti-aging and Longevity Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Anti-aging and Longevity Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anti-aging and Longevity Drugs.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Anti-aging and Longevity Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Anti-aging and Longevity Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

111 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Anti-aging and Longevity Drugs Market Size Estimates and Forecasts (2020-2031)
1.2.2 Global Anti-aging and Longevity Drugs Sales Estimates and Forecasts (2020-2031)
1.3 Anti-aging and Longevity Drugs Market by Type
1.3.1 Resveratrol
1.3.2 Coenzyme Q10 and Collagen
1.3.3 Biotin
1.3.4 Vitamins
1.3.5 Nicotinamide Mononucleotide (NMN)
1.3.6 Others
1.4 Global Anti-aging and Longevity Drugs Market Size by Type
1.4.1 Global Anti-aging and Longevity Drugs Market Size Overview by Type (2020-2031)
1.4.2 Global Anti-aging and Longevity Drugs Historic Market Size Review by Type (2020-2025)
1.4.3 Global Anti-aging and Longevity Drugs Forecasted Market Size by Type (2026-2031)
1.5 Key Regions Market Size by Type
1.5.1 North America Anti-aging and Longevity Drugs Sales Breakdown by Type (2020-2025)
1.5.2 Europe Anti-aging and Longevity Drugs Sales Breakdown by Type (2020-2025)
1.5.3 Asia-Pacific Anti-aging and Longevity Drugs Sales Breakdown by Type (2020-2025)
1.5.4 South America Anti-aging and Longevity Drugs Sales Breakdown by Type (2020-2025)
1.5.5 Middle East and Africa Anti-aging and Longevity Drugs Sales Breakdown by Type (2020-2025)
2 Global Market Dynamics
2.1 Anti-aging and Longevity Drugs Industry Trends
2.2 Anti-aging and Longevity Drugs Industry Drivers
2.3 Anti-aging and Longevity Drugs Industry Opportunities and Challenges
2.4 Anti-aging and Longevity Drugs Industry Restraints
3 Market Competitive Landscape by Company
3.1 Global Top Players by Anti-aging and Longevity Drugs Revenue (2020-2025)
3.2 Global Top Players by Anti-aging and Longevity Drugs Sales (2020-2025)
3.3 Global Top Players by Anti-aging and Longevity Drugs Price (2020-2025)
3.4 Global Anti-aging and Longevity Drugs Industry Company Ranking, 2023 VS 2024 VS 2025
3.5 Global Anti-aging and Longevity Drugs Major Company Production Sites & Headquarters
3.6 Global Anti-aging and Longevity Drugs Company, Product Type & Application
3.7 Global Anti-aging and Longevity Drugs Company Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Anti-aging and Longevity Drugs Market CR5 and HHI
3.8.2 Global Top 5 and 10 Anti-aging and Longevity Drugs Players Market Share by Revenue in 2024
3.8.3 2023 Anti-aging and Longevity Drugs Tier 1, Tier 2, and Tier 3
4 Anti-aging and Longevity Drugs Regional Status and Outlook
4.1 Global Anti-aging and Longevity Drugs Market Size and CAGR by Region: 2020 VS 2024 VS 2031
4.2 Global Anti-aging and Longevity Drugs Historic Market Size by Region
4.2.1 Global Anti-aging and Longevity Drugs Sales in Volume by Region (2020-2025)
4.2.2 Global Anti-aging and Longevity Drugs Sales in Value by Region (2020-2025)
4.2.3 Global Anti-aging and Longevity Drugs Sales (Volume & Value), Price and Gross Margin (2020-2025)
4.3 Global Anti-aging and Longevity Drugs Forecasted Market Size by Region
4.3.1 Global Anti-aging and Longevity Drugs Sales in Volume by Region (2026-2031)
4.3.2 Global Anti-aging and Longevity Drugs Sales in Value by Region (2026-2031)
4.3.3 Global Anti-aging and Longevity Drugs Sales (Volume & Value), Price and Gross Margin (2026-2031)
5 Anti-aging and Longevity Drugs by Application
5.1 Anti-aging and Longevity Drugs Market by Application
5.1.1 Retail Pharmacies
5.1.2 Online Pharmacies
5.1.3 Hospitals
5.1.4 Clinics
5.2 Global Anti-aging and Longevity Drugs Market Size by Application
5.2.1 Global Anti-aging and Longevity Drugs Market Size Overview by Application (2020-2031)
5.2.2 Global Anti-aging and Longevity Drugs Historic Market Size Review by Application (2020-2025)
5.2.3 Global Anti-aging and Longevity Drugs Forecasted Market Size by Application (2026-2031)
5.3 Key Regions Market Size by Application
5.3.1 North America Anti-aging and Longevity Drugs Sales Breakdown by Application (2020-2025)
5.3.2 Europe Anti-aging and Longevity Drugs Sales Breakdown by Application (2020-2025)
5.3.3 Asia-Pacific Anti-aging and Longevity Drugs Sales Breakdown by Application (2020-2025)
5.3.4 South America Anti-aging and Longevity Drugs Sales Breakdown by Application (2020-2025)
5.3.5 Middle East and Africa Anti-aging and Longevity Drugs Sales Breakdown by Application (2020-2025)
6 Company Profiles
6.1 Centrum
6.1.1 Centrum Comapny Information
6.1.2 Centrum Business Overview
6.1.3 Centrum Anti-aging and Longevity Drugs Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Centrum Anti-aging and Longevity Drugs Product Portfolio
6.1.5 Centrum Recent Developments
6.2 GNC
6.2.1 GNC Comapny Information
6.2.2 GNC Business Overview
6.2.3 GNC Anti-aging and Longevity Drugs Sales, Revenue and Gross Margin (2020-2025)
6.2.4 GNC Anti-aging and Longevity Drugs Product Portfolio
6.2.5 GNC Recent Developments
6.3 Herbalmax
6.3.1 Herbalmax Comapny Information
6.3.2 Herbalmax Business Overview
6.3.3 Herbalmax Anti-aging and Longevity Drugs Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Herbalmax Anti-aging and Longevity Drugs Product Portfolio
6.3.5 Herbalmax Recent Developments
6.4 HUM Nutrition
6.4.1 HUM Nutrition Comapny Information
6.4.2 HUM Nutrition Business Overview
6.4.3 HUM Nutrition Anti-aging and Longevity Drugs Sales, Revenue and Gross Margin (2020-2025)
6.4.4 HUM Nutrition Anti-aging and Longevity Drugs Product Portfolio
6.4.5 HUM Nutrition Recent Developments
6.5 MegaFood
6.5.1 MegaFood Comapny Information
6.5.2 MegaFood Business Overview
6.5.3 MegaFood Anti-aging and Longevity Drugs Sales, Revenue and Gross Margin (2020-2025)
6.5.4 MegaFood Anti-aging and Longevity Drugs Product Portfolio
6.5.5 MegaFood Recent Developments
6.6 Natrol
6.6.1 Natrol Comapny Information
6.6.2 Natrol Business Overview
6.6.3 Natrol Anti-aging and Longevity Drugs Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Natrol Anti-aging and Longevity Drugs Product Portfolio
6.6.5 Natrol Recent Developments
6.7 Nature Made
6.7.1 Nature Made Comapny Information
6.7.2 Nature Made Business Overview
6.7.3 Nature Made Anti-aging and Longevity Drugs Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Nature Made Anti-aging and Longevity Drugs Product Portfolio
6.7.5 Nature Made Recent Developments
6.8 Nature's Bounty
6.8.1 Nature's Bounty Comapny Information
6.8.2 Nature's Bounty Business Overview
6.8.3 Nature's Bounty Anti-aging and Longevity Drugs Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Nature's Bounty Anti-aging and Longevity Drugs Product Portfolio
6.8.5 Nature's Bounty Recent Developments
6.9 New Chapter
6.9.1 New Chapter Comapny Information
6.9.2 New Chapter Business Overview
6.9.3 New Chapter Anti-aging and Longevity Drugs Sales, Revenue and Gross Margin (2020-2025)
6.9.4 New Chapter Anti-aging and Longevity Drugs Product Portfolio
6.9.5 New Chapter Recent Developments
6.10 Pure Encapsulations
6.10.1 Pure Encapsulations Comapny Information
6.10.2 Pure Encapsulations Business Overview
6.10.3 Pure Encapsulations Anti-aging and Longevity Drugs Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Pure Encapsulations Anti-aging and Longevity Drugs Product Portfolio
6.10.5 Pure Encapsulations Recent Developments
6.11 The Vitamin Shoppe
6.11.1 The Vitamin Shoppe Comapny Information
6.11.2 The Vitamin Shoppe Business Overview
6.11.3 The Vitamin Shoppe Anti-aging and Longevity Drugs Sales, Revenue and Gross Margin (2020-2025)
6.11.4 The Vitamin Shoppe Anti-aging and Longevity Drugs Product Portfolio
6.11.5 The Vitamin Shoppe Recent Developments
6.12 China Resources Double-Crane Pharmaceutical Co.,Ltd.
6.12.1 China Resources Double-Crane Pharmaceutical Co.,Ltd. Comapny Information
6.12.2 China Resources Double-Crane Pharmaceutical Co.,Ltd. Business Overview
6.12.3 China Resources Double-Crane Pharmaceutical Co.,Ltd. Anti-aging and Longevity Drugs Sales, Revenue and Gross Margin (2020-2025)
6.12.4 China Resources Double-Crane Pharmaceutical Co.,Ltd. Anti-aging and Longevity Drugs Product Portfolio
6.12.5 China Resources Double-Crane Pharmaceutical Co.,Ltd. Recent Developments
6.13 GeneHarbor (Hong Kong) Biotechnologies Limited
6.13.1 GeneHarbor (Hong Kong) Biotechnologies Limited Comapny Information
6.13.2 GeneHarbor (Hong Kong) Biotechnologies Limited Business Overview
6.13.3 GeneHarbor (Hong Kong) Biotechnologies Limited Anti-aging and Longevity Drugs Sales, Revenue and Gross Margin (2020-2025)
6.13.4 GeneHarbor (Hong Kong) Biotechnologies Limited Anti-aging and Longevity Drugs Product Portfolio
6.13.5 GeneHarbor (Hong Kong) Biotechnologies Limited Recent Developments
6.14 Xiamen Kingdomway Group Company
6.14.1 Xiamen Kingdomway Group Company Comapny Information
6.14.2 Xiamen Kingdomway Group Company Business Overview
6.14.3 Xiamen Kingdomway Group Company Anti-aging and Longevity Drugs Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Xiamen Kingdomway Group Company Anti-aging and Longevity Drugs Product Portfolio
6.14.5 Xiamen Kingdomway Group Company Recent Developments
6.15 Shinkowa
6.15.1 Shinkowa Comapny Information
6.15.2 Shinkowa Business Overview
6.15.3 Shinkowa Anti-aging and Longevity Drugs Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Shinkowa Anti-aging and Longevity Drugs Product Portfolio
6.15.5 Shinkowa Recent Developments
6.16 Yaben Chemical
6.16.1 Yaben Chemical Comapny Information
6.16.2 Yaben Chemical Business Overview
6.16.3 Yaben Chemical Anti-aging and Longevity Drugs Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Yaben Chemical Anti-aging and Longevity Drugs Product Portfolio
6.16.5 Yaben Chemical Recent Developments
6.17 Guangdong Zhongsheng Pharmaceutical Co.,Ltd.
6.17.1 Guangdong Zhongsheng Pharmaceutical Co.,Ltd. Comapny Information
6.17.2 Guangdong Zhongsheng Pharmaceutical Co.,Ltd. Business Overview
6.17.3 Guangdong Zhongsheng Pharmaceutical Co.,Ltd. Anti-aging and Longevity Drugs Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Guangdong Zhongsheng Pharmaceutical Co.,Ltd. Anti-aging and Longevity Drugs Product Portfolio
6.17.5 Guangdong Zhongsheng Pharmaceutical Co.,Ltd. Recent Developments
7 North America by Country
7.1 North America Anti-aging and Longevity Drugs Sales by Country
7.1.1 North America Anti-aging and Longevity Drugs Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.1.2 North America Anti-aging and Longevity Drugs Sales by Country (2020-2025)
7.1.3 North America Anti-aging and Longevity Drugs Sales Forecast by Country (2026-2031)
7.2 North America Anti-aging and Longevity Drugs Market Size by Country
7.2.1 North America Anti-aging and Longevity Drugs Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.2.2 North America Anti-aging and Longevity Drugs Market Size by Country (2020-2025)
7.2.3 North America Anti-aging and Longevity Drugs Market Size Forecast by Country (2026-2031)
8 Europe by Country
8.1 Europe Anti-aging and Longevity Drugs Sales by Country
8.1.1 Europe Anti-aging and Longevity Drugs Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.1.2 Europe Anti-aging and Longevity Drugs Sales by Country (2020-2025)
8.1.3 Europe Anti-aging and Longevity Drugs Sales Forecast by Country (2026-2031)
8.2 Europe Anti-aging and Longevity Drugs Market Size by Country
8.2.1 Europe Anti-aging and Longevity Drugs Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.2.2 Europe Anti-aging and Longevity Drugs Market Size by Country (2020-2025)
8.2.3 Europe Anti-aging and Longevity Drugs Market Size Forecast by Country (2026-2031)
9 Asia-Pacific by Country
9.1 Asia-Pacific Anti-aging and Longevity Drugs Sales by Country
9.1.1 Asia-Pacific Anti-aging and Longevity Drugs Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.1.2 Asia-Pacific Anti-aging and Longevity Drugs Sales by Country (2020-2025)
9.1.3 Asia-Pacific Anti-aging and Longevity Drugs Sales Forecast by Country (2026-2031)
9.2 Asia-Pacific Anti-aging and Longevity Drugs Market Size by Country
9.2.1 Asia-Pacific Anti-aging and Longevity Drugs Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.2.2 Asia-Pacific Anti-aging and Longevity Drugs Market Size by Country (2020-2025)
9.2.3 Asia-Pacific Anti-aging and Longevity Drugs Market Size Forecast by Country (2026-2031)
10 South America by Country
10.1 South America Anti-aging and Longevity Drugs Sales by Country
10.1.1 South America Anti-aging and Longevity Drugs Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.1.2 South America Anti-aging and Longevity Drugs Sales by Country (2020-2025)
10.1.3 South America Anti-aging and Longevity Drugs Sales Forecast by Country (2026-2031)
10.2 South America Anti-aging and Longevity Drugs Market Size by Country
10.2.1 South America Anti-aging and Longevity Drugs Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.2.2 South America Anti-aging and Longevity Drugs Market Size by Country (2020-2025)
10.2.3 South America Anti-aging and Longevity Drugs Market Size Forecast by Country (2026-2031)
11 Middle East and Africa by Country
11.1 Middle East and Africa Anti-aging and Longevity Drugs Sales by Country
11.1.1 Middle East and Africa Anti-aging and Longevity Drugs Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.1.2 Middle East and Africa Anti-aging and Longevity Drugs Sales by Country (2020-2025)
11.1.3 Middle East and Africa Anti-aging and Longevity Drugs Sales Forecast by Country (2026-2031)
11.2 Middle East and Africa Anti-aging and Longevity Drugs Market Size by Country
11.2.1 Middle East and Africa Anti-aging and Longevity Drugs Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.2.2 Middle East and Africa Anti-aging and Longevity Drugs Market Size by Country (2020-2025)
11.2.3 Middle East and Africa Anti-aging and Longevity Drugs Market Size Forecast by Country (2026-2031)
12 Value Chain and Sales Channels Analysis
12.1 Anti-aging and Longevity Drugs Value Chain Analysis
12.1.1 Anti-aging and Longevity Drugs Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Anti-aging and Longevity Drugs Production Mode & Process
12.2 Anti-aging and Longevity Drugs Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Anti-aging and Longevity Drugs Distributors
12.2.3 Anti-aging and Longevity Drugs Customers
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.